|
INBX Inhibrx Biosciences Inc 2007919 |
| Balance Sheet |
|
Current Assets
|
$171,341,000.00 |
|
Assets
|
$183,967,000.00 |
|
Current Liabilities
|
$26,512,000.00 |
|
Liabilities
|
$205,002,000.00 |
|
Equity
|
$-21,035,000.00 |
|
Shares Out
|
14607286.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-38,026,000.00 |
| Market Analysis |
Market Cap
|
$1,237,675,342.78 |
|
Price
|
$81.18 |
|
PB
|
1.03 |
|
EPS
|
-2.15 |
|
PS
|
1096.45 |
|
FCF
|
$-38,026,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:24 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:20 |
|
| Apr |
May |
Jun |
| 2026-03-19 |
-2.11 |
|
|
2026-05-14 |
-2.15 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-13 |
-1.85 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-14 |
-2.28 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view INBX documents filed with the SEC.
INBX Filings
Clear
